Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 7/20 | 0.98 |
| ▸ | CTSS | P25774 | 7/20 | 0.98 |
| ▸ | CTSK | P43235 | 7/20 | 0.98 |
| ▸ | CTSB | P07858 | 5/20 | 0.98 |
| ▸ | CTSV | O60911 | 2/20 | 0.68 |
| ▸ | PLAT | P00750 | 2/20 | 0.68 |
| ▸ | CTSH | P09668 | 2/20 | 0.68 |
| ▸ | CASP14 | P31944 | 2/20 | 0.68 |
| ▸ | CASP6 | P55212 | 2/20 | 0.68 |
| ▸ | CTSZ | Q9UBR2 | 2/20 | 0.68 |
| ▸ | CASP4 | P49662 | 1/20 | 0.57 |
| ▸ | CASP5 | P51878 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5032293 | 0.85 | CTSL (0.76) | CTSLCTSSCTSKCTSBCTSV | |
| SCHEMBL3348177 | 0.81 | CTSS (0.75) | CTSLCTSSCTSKCTSBCTSV | |
| SCHEMBL3350907 | 0.81 | CTSS (1.00) | CTSLCTSSCTSKCTSBCTSV | |
| SCHEMBL3346441 | 0.81 | CTSS (0.75) | CTSLCTSSCTSKCTSBCTSV | |
| SCHEMBL5031277 | 0.75 | CTSL (0.61) | CTSLCTSSCTSKCTSB | |
| SCHEMBL27223333 | 0.75 | ABCG2 (0.68) | CTSLCTSSCTSKCTSB | |
| SCHEMBL3475933 | 0.75 | NPC1 (0.67) | CTSLCTSSCTSKCTSB | |
| SCHEMBL30780915 | 0.73 | MAPT (0.61) | CTSLCTSSCTSKCTSB | |
| SCHEMBL16010896 | 0.73 | ALDH1A1 (0.65) | CTSLCTSSCTSKCTSB | |
| SCHEMBL3347831 | 0.73 | CTSS (1.00) | CTSLCTSSCTSKCTSBCTSV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010059418-A1 | SUBSTITUTED TRIAZINE AND PURINE COMPOUNDS, METHODS OF INHIBITING CRUZAIN AND RHODESAIN AND METHODS OF TREATING CHAGAS DISEASE AND AFRICAN TRYPANOSOMIASIS | THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES (US) | 2010-05-27 | — | — | WO | disclosed |
| WO-2010059418-A1 | SUBSTITUTED TRIAZINE AND PURINE COMPOUNDS, METHODS OF INHIBITING CRUZAIN AND RHODESAIN AND METHODS OF TREATING CHAGAS DISEASE AND AFRICAN TRYPANOSOMIASIS | THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES (US) | 2010-05-27 | — | — | WO | disclosed |